Trial intelligence / Profile preview

Voriconazole PK and Safety in Hospitalized Children

NCT00174473Phase 2Completed

Sponsor
Pfizer
Start
Jun 2003
Modality
Orthosteric Ligands
01

Overview

A Phase 2 trial of voriconazole in fungal infection, sponsored by Pfizer. Started Jun 2003; status: completed.

02

Drugs

voriconazole
03

Conditions

fungal infection

Beyond the preview

Go deeper on NCT00174473.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00174473.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call